Stifel abaisse l’objectif de cours de l’action Nkarta à 11€ contre 12€, maintient la recommandation d’achat
Nkarta Appoints Shawn Rose Chief Medical Officer & Head of R&D as Company Resets Senior Leadership Role for Autoimmune Focus
This Alcoa Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday - Alcoa (NYSE:AA), Americold Realty Trust (NYSE:COLD)